Portfolio (Quarterly)
Guide ↗
SAMSARA BIOCAPITAL, LLC
· CIK 0001744967| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 6,897,652.0 | $303.8M | 31.35% | +1.3M | +22.9% | $44.05 | +9.3% |
| 2 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 12,948,081.0 | $109.3M | 11.28% | +1.5M | +13.1% | $8.44 | -41.7% |
| 3 | ALMS | ALUMIS INC | Healthcare | 5,756,984.0 | $56.2M | 5.80% | +956K | +19.9% | $9.76 | +125.6% |
| 4 | GOSS | GOSSAMER BIO INC | Healthcare | 7,222,559.0 | $22.4M | 2.31% | +1.1M | +17.8% | $3.10 | -93.2% |
| 5 | JBIO | JADE BIOSCIENCES INC | Healthcare | 968,798.0 | $14.9M | 1.54% | +438K | +82.4% | $15.43 | +43.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%